Related Experiment Video
Updated: May 5, 2026

Cerebellar Regional Dissection for Molecular Analysis
Published on: December 5, 2020
Rapidly progressive cerebellar ataxia in West Wales
Khalid Ali1, Reem Amin, Kathir G Yoganathan
1Neurology Department, Morriston Hospital, Swansea, UK.
Insights
Progressive multifocal leukoencephalopathy (PML), a severe brain disease caused by JC virus, affects immunocompromised individuals. Treatment focuses on immune reconstitution, as demonstrated in an HIV-positive patient with cerebellar ataxia.
Area of Science:
- Neuroscience
- Infectious Diseases
Background:
- Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating central nervous system disease caused by JC virus infection, often leading to fatal or disabling outcomes.
- PML occurs in patients with cell-mediated immunosuppression, historically linked to hematological malignancies and rheumatological diseases, with a significant increase in incidence due to the HIV epidemic.
- The advent of monoclonal antibody therapies, such as natalizumab for multiple sclerosis, has also been associated with PML development.
Observation:
- Clinical presentation includes cognitive decline, visual disturbances, and hemiparesis.
- Diagnosis is typically established through clinicoradiological findings and detection of JC virus DNA in cerebrospinal fluid (CSF) via PCR, with brain biopsy rarely required.
Findings:
- The case study details a 47-year-old male presenting with progressive cerebellar ataxia, confirmed as PML.
- Investigations revealed the patient was HIV positive, highlighting a common risk factor for PML.
- Literature review on PML management and presentation is included.
Implications:
- Immune reconstitution is the primary therapeutic strategy for managing PML.
- Understanding the diverse etiologies and clinical presentations of PML is crucial for timely diagnosis and management.
- The association of PML with both viral infections and iatrogenic immunosuppression underscores the importance of monitoring immune status in at-risk populations.
Abstract:
Progressive multifocal leucoencephalopathy (PML) is a severe demyelinating disease of the central nervous system that is caused by the JC virus infection. It is often fatal or severely disabling. PML exclusively happens in the context of cell-mediated immunosuppression. Prior to the era of HIV, PML was mainly confined to patients with haematological malignancies and rheumatological diseases. The HIV epidemic in the early eighties led to massive expansion in the incidence and prevalence of the disease. PML has also been recognised to happen due to treatment with monoclonal antibodies such as natalizumab, which is used as a disease-modifying agent for relapsing remitting multiple sclerosis and other monoclonal antibodies used in dermatological and haematological conditions. The clinical picture is that of cognitive decline, visual disturbance and hemiparesis. The correct clinicoradiological picture combined with demonstrating the JC virus DNA in the cerebrospinal fluid (CSF) using PCR (PMR) is enough to establish the diagnosis. Brain biopsy is rarely needed. Immune reconstitution represents the mainstay in the treatment of PML. We present a case of a 47-year-old man who presented with progressive cerebellar ataxia. Investigations confirmed PML. He was found to be HIV positive. We also review the literature.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Huntington Disease l: Introduction
Alzheimer Disease l: Introduction
Dementia l: Introduction

